Konstantin Slobodnyuk

Konstantin Slobodnyuk is a highly experienced senior translational scientist at Merus N.V. since September 2022, with a robust background in cancer research and molecular biology. Previous roles include postdoctoral fellow at Vall d´Hebron Institute of Research, where responsibilities encompassed working with patient-derived organoids and investigating cell communication in breast cancer. Slobodnyuk has contributed to various research initiatives, including as a visiting researcher at Prinses Máxima Centrum for pediatric oncology and as an investigator in postdoctoral positions at Universitat Pompeu Fabra, focusing on Duchenne Muscular Dystrophy and associated cellular mechanisms. Early career experience includes significant contributions in hematology-oncology diagnostics at Pavlov First Saint Petersburg State Medical University. Slobodnyuk holds a Ph.D. in Molecular Pharmacology and multiple degrees in molecular biology and bioinformatics, complemented by a master’s in clinical trials monitoring.